Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis

Calogero Camma', Antonio Craxi, Rosaria Maria Pipitone, Antonino Tuttolomondo, Antonio Pinto, Stefania Grimaudo, Salvatore Petta, Vito Di Marco, Marcello Ciaccio, Vincenza Calvaruso, Anna Licata, Luca Rinaldi, Riccardo Nevola, Luca Valenti, Anna Ludovica Fracanzani, Aldo Marrone, Luca Valenti, Silvia Fargion, Luigi Elio Adinolfi, Daniele TorresFrancesca Rini, Rosalia Caldarella

Risultato della ricerca: Articlepeer review

55 Citazioni (Scopus)

Abstract

Recent studies suggest an association between HCV infection and cardiovascular damage, including carotid atherosclerosis, with a possible effect of HCV clearance on cardiovascular outcomes. We aimed to examine whether HCV eradication by direct antiviral agents (DAA) improves carotid atherosclerosis in HCV-infected patients with advanced fibrosis/compensated cirrhosis.
Lingua originaleEnglish
pagine (da-a)18-24
Numero di pagine7
RivistaJournal of Hepatology
Volume69
Stato di pubblicazionePublished - 2018

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2721???

Fingerprint

Entra nei temi di ricerca di 'Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis'. Insieme formano una fingerprint unica.

Cita questo